TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25040429

Group type: EXPERIMENTAL
Intervention: HiSCR achievers
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: HiSCR
Number of subjects: 138
Study: 21883839

Group type: EXPERIMENTAL
Intervention: Tubeless PCNL
Number of subjects: 1365

Group type: COMPARATOR
Intervention: Standard PCNL
Number of subjects: 1365
Study: 20334979

Group type: EXPERIMENTAL
Intervention: Preoperative CRT
Number of subjects: 3913

Group type: COMPARATOR
Intervention: Postoperative CRT
Number of subjects: 3913

Group type: EXPERIMENTAL
Intervention: Chemotherapy added to radiotherapy
Number of subjects: 3913
Study: 18703940

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release (37.5-300 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15802690

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 0
Study: 12877448

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 200 microg used as needed (FP200PRN)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 241
Study: 10382190

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 53
Study: 8730971

Group type: EXPERIMENTAL
Intervention: Clonidine (200 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Tyramine (75 mM; 2 x 10 microliters)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Methoxamine (20 mM; 2 x 10 microliters)
Number of subjects: 8
Study: 1929293

Group type: EXPERIMENTAL
Intervention: Cefonicid (1 g, single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clindamycin (600 mg, every 8 h for a total of four doses)
Number of subjects: 0
Study: 31401841

Group type: EXPERIMENTAL
Intervention: Zumba intervention (twice-weekly group classes)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (maintenance of habitual exercise)
Number of subjects: 53
Study: 31112475

Group type: EXPERIMENTAL
Intervention: Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by involved-field radiotherapy for PET-positive patients (n = 143)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Involved-field radiotherapy (n = 208)
Number of subjects: 562

Group type: COMPARATOR
Intervention: No additional treatment (n = 211)
Number of subjects: 562
Study: 27650876

Group type: EXPERIMENTAL
Intervention: Fixed diet plan
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Calorie-counting diet
Number of subjects: 66
Study: 26017129

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention with a daily checklist, definition of daily care goals during multidisciplinary daily rounds, and clinician prompts.
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 118
Study: 23360820

Group type: EXPERIMENTAL
Intervention: Soluble αKL preoperatively in acromegaly group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Soluble αKL postoperatively in acromegaly group (early follow-up 2-6 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Soluble αKL postoperatively in acromegaly group (late follow-up 2-3 months)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Soluble αKL preoperatively in control group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Soluble αKL postoperatively in control group (early and late follow-up)
Number of subjects: 14
Study: 21506633

Group type: EXPERIMENTAL
Intervention: Multimodal behavior treatment (MBT) with hand massage
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Multimodal behavior treatment (MBT) without hand massage
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study: 20799476

Group type: EXPERIMENTAL
Intervention: IVN201 (functional fusion peptide) administered via intralymphatic immunotherapy (ILIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IVN201 (functional fusion peptide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ILIT (Intralymphatic immunotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MAT molecules (Modular‐Antigen‐Transportation proteins)
Number of subjects: 0
Study: 18025996

Group type: EXPERIMENTAL
Intervention: Carraguard gel
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Genital findings
Number of subjects: 55
Study: 15992794

Group type: EXPERIMENTAL
Intervention: Phonological activation during semantic access in reading Chinese characters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroop effects from semantically congruent, phonologically congruent, semantically incongruent, phonologically incongruent, and neutral relationships
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phonological activation in semantic retrieval
Number of subjects: 0
Study: 12043953

Group type: EXPERIMENTAL
Intervention: Extended-release glipizide GITS (Glucotrol XL) 20 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release glipizide (Glucotrol) 10 mg twice daily
Number of subjects: 0
Study: 10082353

Group type: EXPERIMENTAL
Intervention: European Carotid Surgery Trial measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Common carotid measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: North American Symptomatic Carotid Endarterectomy Trial measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Power Doppler mode after enhancement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Common carotid measurements in power Doppler mode after enhancement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: European Carotid Surgery Trial measurements using nonenhanced power Doppler or color Doppler sonography
Number of subjects: 20
Study: 7737631

Group type: EXPERIMENTAL
Intervention: Intravenous octreotide (25-micrograms bolus)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Intravenous octreotide (infusion of 50-micrograms/hr)
Number of subjects: 59
Study: 2393282

Group type: EXPERIMENTAL
Intervention: Cefprozil 250 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefprozil 500 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cefaclor 250 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cefaclor 500 mg
Number of subjects: 12
Study: 7046034

Group type: EXPERIMENTAL
Intervention: 200 mg ketoprofen per day
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 mg indomethacin per day
Number of subjects: 50
Study: 30829772

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser applied with an interval of 2 weeks for 7 sessions alongside whole-body nb-UVB phototherapy 3 times a week for at least 4 months.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Whole-body nb-UVB phototherapy 3 times a week for at least 4 months (control side).
Number of subjects: 30
Study: 28583869

Group type: EXPERIMENTAL
Intervention: Lumbar total disc replacement (TDR)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Multidisciplinary rehabilitation (MDR)
Number of subjects: 173
Study: 26385341

Group type: EXPERIMENTAL
Intervention: Erythrosine dose of 220 μM
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Continuous irradiation with light for 15 minutes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Light fractionation of 5 × 1 min irradiation separated by 2-min-dark recovery periods
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Erythrosine-based PDT
Number of subjects: 15

Group type: COMPARATOR
Intervention: Current best practice
Number of subjects: 15
Study: 23769763

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo control (sham KT)
Number of subjects: 123
Study: 21411243

Group type: EXPERIMENTAL
Intervention: Osmotic-release methylphenidate (OROS-MPH)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 19690618

Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone-artesunate (CDA) 2/2.5/4 mg/kg once daily for three days (N = 914)
Number of subjects: 1372

Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL) six doses over three days (N = 458)
Number of subjects: 1372
Study: 16273088

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg/ml plus netilmicin 3 mg/ml (n=148)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Dexamethasone 1 mg/ml plus tobramycin 3 mg/ml (n=75, TOBRADEX)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Dexamethasone/netilmicin combination
Number of subjects: 223
Study: 15000504

Group type: EXPERIMENTAL
Intervention: Alcohol group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 11283389

Group type: EXPERIMENTAL
Intervention: Plasma vitamin C (ascorbic acid, AA) levels in ICH and HT patients
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Plasma vitamin C (ascorbic acid, AA) levels in jugular blood samples
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 28
Study: 9041214

Group type: EXPERIMENTAL
Intervention: Programmed 'variable-sodium' dialysis with dialysate sodium starting at 155 mEq/L and decreasing to 135 mEq/L, held constant at 135 mEq/L for the final half hour.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard therapy with dialysate sodium of 140 mEq/L.
Number of subjects: 18
Study: 8179518

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 3283973

Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 100
Study: 28431408

Group type: EXPERIMENTAL
Intervention: Aerobic Mode (AM) - cycling
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Strength Mode (SM) - resistance training
Number of subjects: 16
Study: 26061222

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with mCIMT
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS combined with mCIMT
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham tDCS combined with mCIMT
Number of subjects: 21
Study: 24359312

Group type: EXPERIMENTAL
Intervention: Intradermal locator device
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (traditional fluoroscopy)
Number of subjects: 66
Study: 23884332

Group type: EXPERIMENTAL
Intervention: Supplemental GLA + n-3 PUFAs
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 20719820

Group type: EXPERIMENTAL
Intervention: High intensity task-oriented training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Low intensity physiotherapy programme
Number of subjects: 44
Study: 18627361

Group type: EXPERIMENTAL
Intervention: Brief intervention (4 sessions delivered by outpatient obstetrical nurses and research staff)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 235
Study: 16154851

Group type: EXPERIMENTAL
Intervention: Erythropoietin at a dose of 500 U/kg/week s.c.
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 20
Study: 12324677

Group type: EXPERIMENTAL
Intervention: 100 micro g budesonide
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 400 micro g budesonide
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10357495

Group type: EXPERIMENTAL
Intervention: Immediate zidovudine (AZT) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deferred zidovudine (AZT) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two doses of didanosine (ddI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zidovudine (AZT)
Number of subjects: 0
Study: 8963481

Group type: EXPERIMENTAL
Intervention: Oblong levomepromazine tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Coated levomepromazine tablets
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous infusion (reference)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CYP2D6 polymorphism analysis
Number of subjects: 12
Study: 1903663

Group type: EXPERIMENTAL
Intervention: High energy neutron treatment
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional megavoltage x ray treatment (photon treatment)
Number of subjects: 151
Study: 7236081

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Thermosclerostomy
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 98
Study: 31955835

Group type: EXPERIMENTAL
Intervention: 0.5% chloramine‐T (CT0.5%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% Ricinus communis (RC10%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25% sodium hypochlorite (SH0.25%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative control (water)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Positive control (0.25% sodium hypochlorite)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 60
Study: 28298041

Group type: EXPERIMENTAL
Intervention: IV ibuprofen, scheduled oral acetaminophen, and rescue opioids
Number of subjects: 62

Group type: COMPARATOR
Intervention: IV placebo, scheduled oral acetaminophen, and rescue opioids
Number of subjects: 62
Study: 27826134

Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=74)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard CTHC (n=46)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=74) among less educated smokers (n=49)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard CTHC (n=46) among less educated smokers (n=49)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=55)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard CTHC (n=34)
Number of subjects: 120
Study: 24449161

Group type: EXPERIMENTAL
Intervention: Multilevel analysis of PANSS items
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA) models
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Confirmatory analysis framework
Number of subjects: 507
Study: 23688330

Group type: EXPERIMENTAL
Intervention: Constant-frequency inducer (10 repetitions of a low-frequency pure tone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silence replacing the final inducer tone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constant-frequency inducer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constant-frequency inducers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single deviant (longer tone)
Number of subjects: 0
Study: 20025527

Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 170

Group type: COMPARATOR
Intervention: Comparator (vancomycin-aztreonam, imipenem-cilastatin, levofloxacin, vancomycin, or linezolid)
Number of subjects: 170
Study: 18421281

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Caloric restriction and increased structured exercise (CR+EX)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 46
Study: 16126161

Group type: EXPERIMENTAL
Intervention: internet-based cognitive behavioural panic treatment (CBT) (with email contact)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: therapist-assisted CBT manual
Number of subjects: 55

Group type: COMPARATOR
Intervention: internet-based cognitive behavioural panic treatment (CBT)
Number of subjects: 55
Study: 12640069

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 34
Study: 10763796

Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo instrument (Nottingham Instrumental Activities of Daily Living questionnaire)
Number of subjects: 100
Study: 8980856

Group type: EXPERIMENTAL
Intervention: Headache disorders (lifetime prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Headache disorders (last year prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Headache disorders (last week prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Headache disorders (last 24 hours prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Tension-type headache (last year prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Migraine headache (last year prevalence)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Last week and last 24 hours headache complaints
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Last year prevalence of headache disorders
Number of subjects: 538
Study: 1552466

Group type: EXPERIMENTAL
Intervention: Tetracycline-impregnated fiber only (F)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Scaling and root planing with tetracycline-impregnated fiber application (RP/F)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Scaling and root planing only (RP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-treated control (C)
Number of subjects: 32
Study: 4056076

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 21
Study: 30384767

Group type: EXPERIMENTAL
Intervention: US$2 incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: US$5 incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: US$10 incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: US$0 incentive (control)
Number of subjects: 0
Study: 29617523

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan, 200 mg twice daily
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril, 10 mg twice daily
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study: 26721833

Group type: EXPERIMENTAL
Intervention: HRP2/pLDH rapid diagnostic test (RDT) at enrollment
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Screening at enrollment
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: RDT negative PCR or microscopy positive infections
Number of subjects: 540
Study: 26821227

Group type: COMPARATOR
Intervention: Dexamethasone (2 mg/day for 2 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fish Oil (840 mg/day of EPA + DHA for 3 weeks) with Dexamethasone
Number of subjects: 16
Study: 22878823

Group type: EXPERIMENTAL
Intervention: Tunneled catheter drainage (TCD)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Talc pleurodesis (TP)
Number of subjects: 57
Study: 20837192

Group type: EXPERIMENTAL
Intervention: Ketamine, an anesthetic-analgesic agent, not specified dosage or duration
Number of subjects: 0
Study: 18195219

Group type: EXPERIMENTAL
Intervention: hsUHR‐OCT fundus image
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: hsUHR‐OCT cross‐sectional image
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: geometric disc center location
Number of subjects: 17
Study: 16433245

Group type: EXPERIMENTAL
Intervention: Sampling at 10 p.m. and 8 a.m.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sampling at 9 p.m. and 7 a.m.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sampling at 11 p.m. and 7 a.m.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sampling every 2 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sampling every 3 hours.
Number of subjects: 0
Study: 14758407

Group type: EXPERIMENTAL
Intervention: Training and support for management and prevention of STDs
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control intervention about management of diarrhoea
Number of subjects: 14
Study: 10571797

Group type: EXPERIMENTAL
Intervention: losartan 50 mg q.d.
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: losartan 50 mg plus hydrochlorothiazide (HCTZ) 50 mg q.d.
Number of subjects: 63

Group type: COMPARATOR
Intervention: HCTZ 50 mg q.d.
Number of subjects: 63

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 63
Study: 8927679

Group type: EXPERIMENTAL
Intervention: Low haloperidol plasma level (2 ng/mL)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Moderate haloperidol plasma level (10 ng/mL)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Low haloperidol plasma level (2 ng/mL) followed by moderate (10 ng/mL)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Moderate haloperidol plasma level (10 ng/mL) followed by low (2 ng/mL)
Number of subjects: 65
Study: 1428437

Group type: EXPERIMENTAL
Intervention: Recombinant interferon gamma (rIFN-gamma)
Number of subjects: 6
Study: 3972954

Group type: EXPERIMENTAL
Intervention: Physician interviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self‐administered questionnaires
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse practitioner interviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two physicians' interviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse practitioner interview
Number of subjects: 0
Study: 30674043

Group type: EXPERIMENTAL
Intervention: ADVAGOshoulder orthesis
Number of subjects: 53

Group type: COMPARATOR
Intervention: standard abduction orthesis
Number of subjects: 53
Study: 30054227

Group type: EXPERIMENTAL
Intervention: YESHealth intervention (quarterly reports plus baseline PDQ-S results)
Number of subjects: 720

Group type: COMPARATOR
Intervention: PDQ-S results only
Number of subjects: 720

Group type: COMPARATOR
Intervention: No study information
Number of subjects: 720
Study: 26985729

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) alone for 15 sessions
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) followed by Cognitive-Behavioral Therapy (CBT) integrated with MI (4 MI sessions + 11 CBT sessions)
Number of subjects: 85
Study: 25318780

Group type: EXPERIMENTAL
Intervention: Robot-guided practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unassisted training
Number of subjects: 0
Study: 20473737

Group type: EXPERIMENTAL
Intervention: Chinese medicine therapy (Kunbao Pill and Modified Xiaoyao Pill)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Psychological intervention alone
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Combined therapy (Chinese medicine therapy + psychological intervention)
Number of subjects: 185
Study: 15703770

Group type: EXPERIMENTAL
Intervention: IC-PGE1 + 50 mg sildenafil
Number of subjects: 40

Group type: COMPARATOR
Intervention: IC-PGE1-placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: 50 mg sildenafil
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100 mg sildenafil
Number of subjects: 40